A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Status:
Completed

Trial end date:
2016-06-17

Target enrollment:

Participant gender:

The purpose of the study to determine the relative bioavailability of bimekizumab in healthy subjects

Phase 1

UCB Celltech